Can trazodone cause weight gain in an adult patient with a history of mental health issues, such as depression or bipolar disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Trazodone Cause Weight Gain?

Trazodone is associated with minimal weight gain risk and is not considered a weight-promoting antidepressant. Among antidepressants, trazodone demonstrates a favorable weight profile, particularly when compared to agents like mirtazapine, paroxetine, or amitriptyline that carry substantial weight gain risk.

Weight Profile Evidence

Clinical Trial Data

  • In controlled clinical trials, weight gain occurred in only 1% of patients taking trazodone, which was actually lower than the 5% incidence observed in placebo groups 1
  • Weight loss was reported in 3% of trazodone patients compared to 6% in placebo groups, suggesting weight neutrality rather than weight promotion 1
  • Head-to-head comparisons demonstrate that mirtazapine and paroxetine resulted in significantly higher weight gain than trazodone 2

Comparative Context Among Antidepressants

Trazodone ranks among the more weight-neutral antidepressant options, positioned favorably compared to high-risk agents:

  • Highest risk agents to avoid: Mirtazapine, paroxetine, amitriptyline, lithium, and MAOIs are all associated with significant weight gain 3, 4, 2
  • Weight-neutral options: Trazodone, fluoxetine, and sertraline demonstrate minimal weight effects 4, 2
  • Weight-loss promoting: Bupropion is the only antidepressant consistently associated with weight loss rather than gain 4

Clinical Decision Algorithm

When selecting an antidepressant with weight concerns:

  1. First-line choice: Bupropion if no contraindications exist (seizure disorders, eating disorders, uncontrolled hypertension) 4
  2. Second-line options: Trazodone, fluoxetine, or sertraline for their weight-neutral profiles 4, 2
  3. Avoid: Mirtazapine (highest risk), paroxetine (highest among SSRIs), and amitriptyline (highest among tricyclics) 3, 4, 2

Important Clinical Caveats

Dosing Context Matters

  • Trazodone is frequently prescribed at low doses (50-100 mg) as an off-label hypnotic for insomnia, where weight effects are negligible 5, 6, 7
  • At therapeutic antidepressant doses (150-400 mg daily), weight remains neutral based on clinical trial data 6, 8

Common Pitfalls to Avoid

Do not confuse trazodone with mirtazapine—these are entirely different medications with opposite weight profiles. Mirtazapine is specifically noted by guidelines as being "associated with weight gain" and carries one of the highest risks among all antidepressants 3, 4, 2. This confusion occurs frequently in clinical practice but has significant implications for patient outcomes.

Monitoring Recommendations

  • If prescribing trazodone long-term, monitor weight at baseline and periodically, though significant changes are unlikely 1
  • The most common adverse effects are somnolence, headache, dizziness, and dry mouth—not metabolic effects 1, 5, 6

Special Population Considerations

In elderly patients with depression and concurrent weight loss, trazodone's weight-neutral profile makes it appropriate, whereas mirtazapine might be deliberately chosen for its appetite-stimulating properties if weight gain is therapeutically desired 2. However, for the typical adult patient with mental health issues where weight gain is a concern, trazodone represents a safe choice that will not promote weight gain 1, 5, 6.

References

Guideline

Managing Mirtazapine-Associated Weight Gain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antidepressant-Associated Weight Changes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Off-Label Trazodone Prescription: Evidence, Benefits and Risks.

Current pharmaceutical design, 2015

Research

Antidepressant properties of trazodone.

Clinical pharmacy, 1982

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.